General Information of Drug Off-Target (DOT) (ID: OTH56TIH)

DOT Name NHP2-like protein 1 (SNU13)
Synonyms High mobility group-like nuclear protein 2 homolog 1; OTK27; SNU13 homolog; hSNU13; U4/U6.U5 small nuclear ribonucleoprotein SNU13; U4/U6.U5 tri-snRNP 15.5 kDa protein
Gene Name SNU13
Related Disease
Lung cancer ( )
Lung carcinoma ( )
Bipolar disorder ( )
Fanconi anemia complementation group A ( )
Fanconi's anemia ( )
Prediabetes syndrome ( )
Pseudohypoparathyroidism ( )
UniProt ID
NH2L1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1E7K; 2JNB; 2OZB; 3JCR; 3SIU; 3SIV; 5O9Z; 6AH0; 6AHD; 6QW6; 6QX9; 7MQ8; 7MQ9; 7MQA
Pfam ID
PF01248
Sequence
MTEADVNPKAYPLADAHLTKKLLDLVQQSCNYKQLRKGANEATKTLNRGISEFIVMAADA
EPLEIILHLPLLCEDKNVPYVFVRSKQALGRACGVSRPVIACSVTIKEGSQLKQQIQSIQ
QSIERLLV
Function
Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Involved in pre-mRNA splicing as component of the spliceosome. Binds to the 5'-stem-loop of U4 snRNA and thereby contributes to spliceosome assembly. The protein undergoes a conformational change upon RNA-binding.
Tissue Specificity Ubiquitous.
KEGG Pathway
Ribosome biogenesis in eukaryotes (hsa03008 )
Spliceosome (hsa03040 )
Reactome Pathway
Major pathway of rRNA processing in the nucleolus and cytosol (R-HSA-6791226 )
mRNA Splicing - Major Pathway (R-HSA-72163 )
rRNA modification in the nucleus and cytosol (R-HSA-6790901 )

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Lung cancer DISCM4YA Strong Biomarker [1]
Lung carcinoma DISTR26C Strong Biomarker [1]
Bipolar disorder DISAM7J2 Limited Genetic Variation [2]
Fanconi anemia complementation group A DIS8PZLI Limited Biomarker [3]
Fanconi's anemia DISGW6Q8 Limited Biomarker [3]
Prediabetes syndrome DISH2I53 Limited Biomarker [4]
Pseudohypoparathyroidism DIS183OJ Limited Genetic Variation [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of NHP2-like protein 1 (SNU13). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of NHP2-like protein 1 (SNU13). [12]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of NHP2-like protein 1 (SNU13). [6]
Arsenic DMTL2Y1 Approved Arsenic affects the expression of NHP2-like protein 1 (SNU13). [7]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of NHP2-like protein 1 (SNU13). [8]
Selenium DM25CGV Approved Selenium increases the expression of NHP2-like protein 1 (SNU13). [9]
Azacitidine DMTA5OE Approved Azacitidine increases the expression of NHP2-like protein 1 (SNU13). [10]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of NHP2-like protein 1 (SNU13). [9]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of NHP2-like protein 1 (SNU13). [13]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of NHP2-like protein 1 (SNU13). [14]
PP-242 DM2348V Investigative PP-242 increases the expression of NHP2-like protein 1 (SNU13). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)
1 Drug(s) Affected the Protein Interaction/Cellular Processes of This DOT
Drug Name Drug ID Highest Status Interaction REF
DNCB DMDTVYC Phase 2 DNCB affects the binding of NHP2-like protein 1 (SNU13). [11]
------------------------------------------------------------------------------------

References

1 Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.J Drug Target. 2018 Mar;26(3):222-230. doi: 10.1080/1061186X.2017.1354003. Epub 2017 Jul 18.
2 Genome-wide DNA methylation analysis of patients with imprinting disorders identifies differentially methylated regions associated with novel candidate imprinted genes.J Med Genet. 2014 Apr;51(4):229-38. doi: 10.1136/jmedgenet-2013-102116. Epub 2014 Feb 5.
3 Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia.Nat Commun. 2017 Nov 1;8(1):1238. doi: 10.1038/s41467-017-01439-x.
4 Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity.Molecules. 2018 Jun 19;23(6):1483. doi: 10.3390/molecules23061483.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
7 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
8 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
9 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
10 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
11 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
12 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
13 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
14 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
15 Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.